Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Clover Health's PPO Medicare Advantage plans earn 5 Stars for 2027; HMO plan gets 4.5

Positive Impact 3 of 5 other Written later

CMS awarded Clover Health's PPO Medicare Advantage plans 5 Stars and its HMO plan 4.5 Stars in the 2027 Star Ratings, which affect payments in 2028. The PPO rating reflects CMS removing 20 measures under a May 27, 2026 court decision that is on appeal; with those measures included, the PPO plans would have received 4.5 Stars.

Key points

  • PPO Medicare Advantage plans: 5 Stars; HMO plan: 4.5 Stars, for 2027 (payment year 2028)
  • With the 20 measures included, the PPO plans would have received 4.5 Stars
  • Medicare Advantage membership grew about 48% year over year to more than 157,000 through the first half of 2026, with about 98% in PPO plans
  • Core HEDIS score of 4.82 out of 5 Stars, ranking first among non-SNP PPO plans with over 2,000 members

The filing

CompanyCLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Form8-K, current report
Filed with the SECOct 8, 2026, 7:13 PM ET
Accession number0001801170-26-000250

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.